SIGA Technologies Inc (SIGA): Earnings per share for the last twelve months

Corporate company logo of SIGA Corp (SIGA)

SIGA Technologies, Inc. (SIGA) relies on long-term government contracts for the creation of strategic antiviral stockpiles. The trailing twelve-month earnings per share demonstrate a peak, after which the value is fixed at 0.01. The model is based on outsourcing drug synthesis through CMO partners; however, the volatility of TPOXX government procurement and the approval timelines for new indications create a certain level of revenue instability.

SIGA Technologies, Inc. (SIGA) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/16/2026

Metric breakdowns and analytics for SIGA Corp (SIGA)

- stock price and consensus target price:
- stock exchange capitalization data:
Fundamental company analysis:siga.com (SIGA)
Mass-produced product of SIGA Technologies Inc

The specificity of SIGA Technologies, Inc. (SIGA) lies in its dependence on government biodefense contracts, which creates uneven cash flows. This metric aggregates annual net income, dividing it by the total number of shares to assess the actual return per share; therefore, the rolling 12-month EPS chart allows for the filtering of short-term volatility to determine the true stability of the business.

Analysis of competing companies

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Vir Biotechnology (VIR) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EBS|Net earnings per share for the last four quarters Atea Pharmaceuticals, Inc.|Net earnings per share (EPS TTM) IVVD (invivyd.com)|Enanta Pharmaceuticals, Inc (ENTA) - Net earnings per one share for the last twelve months|INO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters